Therapeutic outcome in prognostic subgroups of de-novo acute myeloid leukemia (AML) and the role of the age factor. A study in 1834 patients of 16 to 84 years No significant financial relationships to ...
Please provide your email address to receive an email when new articles are posted on . Lymphopenia at diagnosis or during follow-up can predict OS among patients with multiple myeloma. Researchers ...
Impact of 24 months of androgen deprivation therapy (ADT) on physical function in men with nonmetastatic prostate cancer. A phase II study of neoadjuvant docetaxel (D) plus bevacizumab (B) in patients ...
The analysis of 11,427 Veterans Administration (VA) hospital patients with multiple myeloma (MM) reveals that lymphopenia affects 53% of patients at diagnosis. The median overall survival was 2.7 ...
DEAR DR. ROACH: I am a female and almost 75 years old. My vital signs are always normal, and I am active, but slightly overweight. I get quarterly blood draws, and every reading is in the normal range ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results